DSM Biologics has entered an agreement to partner with the Australian Governments (Queensland State Government and the Commonwealth of Australia) to design, build and operate a mammalian biopharmaceutical manufacturing facility in Brisbane. The 70,000 sq.-ft. facility will offer mammalian process development and cGMP clinical and commercial manufacturing services. The Queensland State Government and the Commonwealth of Australia will provide full financial funding for the facility, which is par...